Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: Results from a multicenter study

Dabigatran versus warfarin in patients with atrial fibrillation

Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215 · see citing works

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430 · see citing works

Apixaban versus warfarin in patients with atrial fibrillation

Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943 · see citing works

Edoxaban versus warfarin in patients with atrial fibrillation

Giugliano, R. P., Ruff, C. T., Braunwald, E., Murphy, S. A., Wiviott, S. D., Halperin, J. L., Waldo, A. L., Ezekowitz, M. D., Weitz, J. I., Špinar, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1310907 · Cited by 5,164 · see citing works

2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design

Calkins, H., Kuck, K. H., Cappato, R., Brugada, J., Camm, A. J., Chen, S.-A., Crijns, H. J. G., Damiano, R. J., Davies, D. W., DiMarco, J., et al. (2012) · Europace · doi:10.1093/europace/eus027 · Cited by 2,722 · see citing works

Effect of clopidogrel added to aspirin in patients with atrial fibrillation

The ACTIVE Investigators (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901301 · Cited by 2,102 · see citing works

2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design

Calkins, H., Kuck, K., Cappato, R., Brugada, J., Camm, A., Chen, S.-A., Crijns, H., Damiano, R., Davies, D., Dimarco, J., et al. (2012) · Journal of interventional cardiac electrophysiology · doi:10.1007/s10840-012-9672-7 · Cited by 1,959 · see citing works

2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design

Calkins, H., Kuck, K. H., Cappato, R., Brugada, J., Camm, A. J., Chen, S.-A., Crijns, H. J. G., Damiano, R. J., Davies, D. W., DiMarco, J., et al. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2011.12.016 · Cited by 1,456 · see citing works

Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate

Eerenberg, E. S., Kamphuisen, P. W., Sijpkens, M. K., Meijers, J. C. M., Buller, H. R., & Levi, M. M. (2011) · Circulation · doi:10.1161/circulationaha.111.029017 · Cited by 1,353 · see citing works

Prevalence and Causes of Fatal Outcome in Catheter Ablation of Atrial Fibrillation

Cappato, R., Calkins, H. G., Chen, S., Davies, W. D., Iesaka, Y., Kalman, J. M., Kim, Y.-H., Klein, G. J., Natale, A., Packer, D. L., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.022 · Cited by 583 · see citing works

Periprocedural Stroke and Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation With Different Anticoagulation Management

Biase, L. D., Burkhardt, J. D., Santangeli, P., Mohanty, P. K., Sánchez, J., Horton, R., Gallinghouse, G. J., Themistoclakis, S., Rossillo, A., Lakkireddy, D., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.006426 · Cited by 485 · see citing works

Feasibility and Safety of Dabigatran Versus Warfarin for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation

Lakkireddy, D., Reddy, Y. M., Biase, L. D., Vanga, S. R., Santangeli, P., Swarup, V., Pimentel, R., MANSOUR, M. C., d’Ávila, A., Sánchez, J., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.12.014 · Cited by 356 · see citing works

Periprocedural Stroke and Management of Major Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation

Biase, L. D., Burkhardt, J. D., Mohanty, P. K., Sánchez, J., Horton, R., Gallinghouse, G. J., Lakkireddy, D., Verma, A., Khaykin, Y., Hongo, R. H., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.921320 · Cited by 293 · see citing works

Complications of Catheter Ablation for Atrial Fibrillation: Incidence and Predictors

SPRAGG, D. D., Dalal, D., Cheema, A., SCHERR, D., Chilukuri, K., Cheng, A., Henrikson, C. A., Marine, J. E., Berger, R. D., Dong, J., et al. (2008) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2008.01181.x · Cited by 286 · see citing works

Feasibility and Safety of Uninterrupted Rivaroxaban for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation

Lakkireddy, D., Reddy, Y. M., Di Biase, L., Vallakati, A., Mansour, M. C., Santangeli, P., Gangireddy, S., Swarup, V., Chalhoub, F., Atkins, D., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.039 · Cited by 177 · see citing works

Ablation of Atrial Fibrillation Under Therapeutic Warfarin Reduces Periprocedural Complications

Santangeli, P., Biase, L. D., Horton, R., Burkhardt, J. D., Sánchez, J., Al‐Ahmad, A., Hongo, R. H., Beheiry, S., Bai, R., Mohanty, P. K., et al. (2012) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.111.964916 · Cited by 172 · see citing works

Use of Dabigatran for Periprocedural Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation

Bassiouny, M., Saliba, W. I., Rickard, J., Shao, M., Sey, A., Diab, M., Martin, D. O., Hussein, A. A., Khoury, M., Abi‐Saleh, B., et al. (2013) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.000320 · Cited by 164 · see citing works

Atrial Fibrillation Ablation Strategies for Paroxysmal Patients

Biase, L. D., Elayi, C. S., Fahmy, T. S. E., Martin, D. O., Ching, C. K., Barrett, C. D., Bai, R., Patel, D., Khaykin, Y., Hongo, R. H., et al. (2009) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.108.798447 · Cited by 158 · see citing works

Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation

Kim, J. S., She, F., Jongnarangsin, K., Chugh, A., Latchamsetty, R., Ghanbari, H., Crawford, T. C., Suwanagool, A., Sinno, M., Carrigan, T., et al. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.12.011 · Cited by 145 · see citing works

Does periprocedural anticoagulation management of atrial fibrillation affect the prevalence of silent thromboembolic lesion detected by diffusion cerebral magnetic resonance imaging in patients undergoing radiofrequency atrial fibrillation ablation with open irrigated catheters? Results from a prospective multicenter study

Biase, L. D., Gaïta, F., Toso, E., Santangeli, P., Mohanty, P. K., Rutledge, N., Yan, X., Mohanty, S., Trivedi, C. G., Bai, R., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.03.003 · Cited by 131 · see citing works

Incidence and Predictors of Periprocedural Cerebrovascular Accident in Patients Undergoing Catheter Ablation of Atrial Fibrillation

SCHERR, D., Sharma, K., Dalal, D., SPRAGG, D. D., Chilukuri, K., Cheng, A., Dong, J., Henrikson, C. A., Nazarian, S., Berger, R. D., et al. (2009) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2009.01540.x · Cited by 123 · see citing works

Safety and efficacy of dabigatran etexilate during catheter ablation of atrial fibrillation: a meta-analysis of the literature

Hohnloser, S. H., & Camm, A. J. (2013) · EP Europace · doi:10.1093/europace/eut241 · Cited by 93 · see citing works

Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a systematic review and meta-analysis

Providencia, R. A., Albenque, J., Combes, S., Bouzeman, A., Casteigt, B. J., Combes, N., Narayanan, K., Marijon, É., & Bovéda, S. (2013) · Heart · doi:10.1136/heartjnl-2013-304386 · Cited by 81 · see citing works

How to ablate long-standing persistent atrial fibrillation?

Biase, L. D., Santangeli, P., & Natale, A. (2012) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32835b59bb · Cited by 65 · see citing works

A comparison of bleeding complications post-ablation between warfarin and dabigatran

Snipelisky, D., Kauffman, C. B., Prussak, K. A., Johns, G. S., Venkatachalam, K. L., & Kusumoto, F. M. (2012) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-012-9708-z · Cited by 63 · see citing works

Comparison of Safety of Left Atrial Catheter Ablation Procedures for Atrial Arrhythmias Under Continuous Anticoagulation With Apixaban Versus Phenprocoumon

Kaess, B. M., Ammar, S., Reents, T., Dillier, R., Lennerz, C., Semmler, V., Grebmer, C., Bourier, F. J., Buiatti, A., Kolb, C., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.10.005 · Cited by 62 · see citing works

Efficacy and Safety of Apixaban in the Patients Undergoing the Ablation of Atrial Fibrillation

Nagao, T., Inden, Y., Shimano, M., Fujita, M., Yanagisawa, S., Kato, H., Ishikawa, S., Miyoshi, A., OKUMURA, S., Ohguchi, S., et al. (2014) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12553 · Cited by 50 · see citing works

Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation: a meta-analysis of observational studies

Steinberg, B. A., Hasselblad, V., Atwater, B. D., Bahnson, T. D., Washam, J. B., Alexander, J. H., Daubert, J. P., & Piccini, J. P. (2013) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-013-9813-7 · Cited by 43 · see citing works

Peri-procedural anticoagulation in patients undergoing ablation for atrial fibrillation

Vazquez, S. R., Johnson, S. A., & Rondina, M. T. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2009.11.031 · Cited by 39 · see citing works

Meta-Analysis of Risk of Stroke or Transient Ischemic Attack With Dabigatran for Atrial Fibrillation Ablation

Sardar, P., Nairooz, R. S., Chatterjee, S., Wetterslev, J., Ghosh, J., & Aronow, W. S. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.12.027 · Cited by 39 · see citing works

Nonadherence with INR Monitoring and Anticoagulant Complications

Witt, D. M., Delate, T., Clark, N. P., Garcia, D. A., Hylek, E. M., Ageno, W., Dentali, F., & Crowther, M. A. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.06.006 · Cited by 37 · see citing works

Thromboembolic Risk and Anticoagulation Strategies in Patients Undergoing Catheter Ablation for Atrial Fibrillation

Viles-González, J. F., & Mehta, D. (2010) · Current Cardiology Reports · doi:10.1007/s11886-010-0153-2 · Cited by 28 · see citing works

Safety and Efficacy of Dabigatran Compared With Warfarin for Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-analysis

Shurrab, M., Morillo, C. A., Schulman, S., Kansal, N., Danon, A., Newman, D. M., Lashevsky, I., Healey, J. S., & Crystal, E. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.07.005 · Cited by 27 · see citing works

Rationale and design of VENTURE-AF: a randomized, open-label, active-controlled multicenter study to evaluate the safety of rivaroxaban and vitamin K antagonists in subjects undergoing catheter ablation for atrial fibrillation

on behalf of the VENTURE-AF Investigators, Naccarelli, G. V., Cappato, R., Hohnloser, S. H., Marchlinski, F. E., Wilber, D. J., Xiang, J. X., Ma, C., Hess, S., Davies, D. W., et al. (2014) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-014-9924-9 · Cited by 16 · see citing works

Apixaban is Dear to Me, but Dearer Still is Warfarin

Biase, L. D., & Natale, A. (2015) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12570 · Cited by 11 · see citing works

Safety and efficacy of novel oral anticoagulants in the setting of atrial fibrillation ablation: Is it time to celebrate the “funeral” of warfarin?

Biase, L. D. (2014) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-014-9944-5 · Cited by 11 · see citing works

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438 · see citing works

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418 · see citing works

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation

Calkins, H. G., Hindricks, G., Cappato, R., Kim, Y., Saad, E., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, A. J., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.05.012 · Cited by 2,771 · see citing works

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

Steffel, J., Verhamme, P., Potpara, T. S., Albaladejo, P., Antz, M., Desteghe, L., Haeusler, K. G., Oldgren, J., Reinecke, H., Roldan-Schilling, V., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy136 · Cited by 2,123 · see citing works

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403 · see citing works

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation

Calkins, H. G., Hindricks, G., Cappato, R., Kim, Y., Saad, E., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, A. J., et al. (2017) · EP Europace · doi:10.1093/europace/eux274 · Cited by 1,191 · see citing works

2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

Steffel, J., Collins, R., Antz, M., Cornu, P., Desteghe, L., Haeusler, K. G., Oldgren, J., Reinecke, H., Roldan-Schilling, V., Rowell, N., et al. (2021) · EP Europace · doi:10.1093/europace/euab065 · Cited by 1,132 · see citing works

Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation

Heidbüchel, H., Verhamme, P. B., Alings, M., Antz, M., Diener, H., Hacke, W., Oldgren, J., Sinnaeve, P., Camm, A. J., & Kirchhof, P. F. (2015) · EP Europace · doi:10.1093/europace/euv309 · Cited by 1,114 · see citing works

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary

Calkins, H. G., Hindricks, G., Cappato, R., Kim, Y., Saad, E., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, A. J., et al. (2017) · Journal of Arrhythmia · doi:10.1016/j.joa.2017.08.001 · Cited by 709 · see citing works

2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation

Tzeis, S. E., Gerstenfeld, E. P., Kalman, J. M., Saad, E., Shamloo, A. S., Andrade, J. G., Barbhaiya, C. R., Baykaner, T., Bovéda, S., Calkins, H. G., et al. (2024) · EP Europace · doi:10.1093/europace/euae043 · Cited by 692 · see citing works

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary

Calkins, H. G., Hindricks, G., Cappato, R., Kim, Y., Saad, E., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, A. J., et al. (2017) · EP Europace · doi:10.1093/europace/eux275 · Cited by 510 · see citing works

Left Atrial Appendage Isolation in Patients With Longstanding Persistent AF Undergoing Catheter Ablation

Biase, L. D., Burkhardt, J. D., Mohanty, P. K., Mohanty, S., Sánchez, J., Trivedi, C. G., Günes, M. F., Gökoğlan, Y., Gianni, C., Horton, R., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.07.770 · Cited by 444 · see citing works

2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation

Tzeis, S. E., Gerstenfeld, E. P., Kalman, J. M., Saad, E., Shamloo, A. S., Andrade, J. G., Barbhaiya, C. R., Baykaner, T., Bovéda, S., Calkins, H. G., et al. (2024) · Heart Rhythm · doi:10.1016/j.hrthm.2024.03.017 · Cited by 312 · see citing works

2020 Clinical guidelines for Atrial fibrillation and atrial flutter

Arakelyan, M. S., Bockeria, L. A., Vasilieva, E., Sp, G., Golukhova, E. Z., Gorev, M. V., Davtyan, K. V., Drapkina, O. M., Станиславовна, К. Е., Kuchinskaya, Е. А., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4594 · Cited by 255 · see citing works

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary

Calkins, H. G., Hindricks, G., Cappato, R., Kim, Y., Saad, E., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, A. J., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.07.009 · Cited by 225 · see citing works

JCS/JHRS 2019 Guideline on Non-Pharmacotherapy of Cardiac Arrhythmias

Nogami, A., Kurita, T., Abe, H., Andò, K., Ishikawa, T., Imai, K., Usui, A., Okishige, K., Kusano, K., Kumagai, K., et al. (2021) · Circulation Journal · doi:10.1253/circj.cj-20-0637 · Cited by 203 · see citing works

JCS/JHRS 2019 guideline on non‐pharmacotherapy of cardiac arrhythmias

Nogami, A., Kurita, T., Abe, H., Andò, K., Ishikawa, T., Imai, K., Usui, A., Okishige, K., Kusano, K., Kumagai, K., et al. (2021) · Journal of Arrhythmia · doi:10.1002/joa3.12491 · Cited by 164 · see citing works

2018 Korean Guideline of Atrial Fibrillation Management

Joung, B., Lee, J., Lee, K. H., Kim, T., Choi, E., Lim, W., Kang, K., Uhm, J., Lim, H. E., Park, J., et al. (2018) · Korean Circulation Journal · doi:10.4070/kcj.2018.0339 · Cited by 154 · see citing works

Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1

Diener, H., Aisenberg, J., Ansell, J., Atar, D., BREITHARDT, G. E., Eikelboom, J. W., Ezekowitz, M. D., Granger, C. B., Halperin, J. L., Hohnloser, S. H., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv643 · Cited by 147 · see citing works

2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation

Chiang, C., Wu, T.-J., Ueng, K.-C., Chao, T., Chang, K., Wang, C.-C., Lin, Y., Yin, W., Kuo, J., Lin, W., et al. (2016) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2016.10.005 · Cited by 138 · see citing works

Use of non-warfarin oral anticoagulants instead of warfarin during left atrial appendage closure with the Watchman device

Enomoto, Y., Gadiyaram, V. K., Gianni, C., Horton, R., Trivedi, C. G., Mohanty, S., Biase, L. D., Al‐Ahmad, A., Burkhardt, J. D., Narula, A., et al. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2016.10.020 · Cited by 111 · see citing works

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary

Calkins, H. G., Hindricks, G., Cappato, R., Kim, Y., Saad, E., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, A. J., et al. (2017) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-017-0277-z · Cited by 100 · see citing works

Perioperative management of anticoagulant and antiplatelet therapy

Tafur, A. J., & Douketis, J. D. (2017) · Heart · doi:10.1136/heartjnl-2016-310581 · Cited by 89 · see citing works

Apixaban versus Warfarin for the Prevention of Periprocedural Cerebral Thromboembolism in Atrial Fibrillation Ablation: Multicenter Prospective Randomized Study

Kuwahara, T., Abe, M., Yamaki, M., Fujieda, H., Abe, Y., HASHIMOTO, K., ISHIBA, M., Sakai, H., Hishikari, K., Takigawa, M., et al. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12928 · Cited by 87 · see citing works

An updated meta-analysis of novel oral anticoagulants versus vitamin K antagonists for uninterrupted anticoagulation in atrial fibrillation catheter ablation

Cardoso, R. N., Knijnik, L., Bhonsale, A., Miller, J., Nasi, G. M., Rivera, M., Blumer, V. L., & Calkins, H. G. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.09.011 · Cited by 86 · see citing works

2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation

Tzeis, S. E., Gerstenfeld, E. P., Kalman, J. M., Saad, E., Shamloo, A. S., Andrade, J. G., Barbhaiya, C. R., Baykaner, T., Bovéda, S., Calkins, H. G., et al. (2024) · Journal of Arrhythmia · doi:10.1002/joa3.13082 · Cited by 76 · see citing works

Clinical Impact of Heparin Kinetics During Catheter Ablation of Atrial Fibrillation: Meta‐Analysis and Meta‐Regression

Briceno, D. F., Villablanca, P. A., Lupercio, F. A., Kargoli, F., Jagannath, A., Jimenez, A. L., Patel, J., Otusanya, O., Brevik, J., Maraboto, C., et al. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12975 · Cited by 67 · see citing works

Uninterrupted vs. interrupted periprocedural direct oral anticoagulants for catheter ablation of atrial fibrillation: a prospective randomized single-centre study on post-ablation thrombo-embolic and haemorrhagic events

Nakamura, K., Naito, S., Sasaki, T., Take, Y., Minami, K., Kitagawa, Y., Motoda, H., Inoue, M., Otsuka, Y., Niijima, K., et al. (2018) · EP Europace · doi:10.1093/europace/euy148 · Cited by 67 · see citing works

2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation

Tzeis, S. E., Gerstenfeld, E. P., Kalman, J. M., Saad, E., Shamloo, A. S., Andrade, J. G., Barbhaiya, C. R., Baykaner, T., Bovéda, S., Calkins, H. G., et al. (2024) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-024-01771-5 · Cited by 66 · see citing works

Ablation of Atrial Fibrillation

Link, M. S., Haı̈ssaguerre, M., & Natale, A. (2016) · Circulation · doi:10.1161/circulationaha.116.021727 · Cited by 64 · see citing works

A Prospective Randomized Trial of Apixaban Dosing During Atrial Fibrillation Ablation

Reynolds, M. R., Allison, J. S., Natale, A., Weisberg, I., Ellenbogen, K. A., Richards, M., Hsieh, W.-H., Sutherland, J., & Cannon, C. P. (2017) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2017.11.005 · Cited by 64 · see citing works

Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants Compared With Uninterrupted Vitamin K Antagonists in Patients Undergoing Catheter Ablation for Atrial Fibrillation

Wu, S., Yang, Y., Zhu, J., Wan, H., Wang, J., Zhang, H., & Shao, X. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.12.027 · Cited by 61 · see citing works

Is transesophageal echocardiogram mandatory in patients undergoing ablation of atrial fibrillation with uninterrupted novel oral anticoagulants? Results from a prospective multicenter registry

Biase, L. D., Briceno, D. F., Trivedi, C. G., Mohanty, S., Gianni, C., Burkhardt, J. D., Mohanty, P. K., Bai, R., Gunda, S., Horton, R., et al. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2016.03.024 · Cited by 57 · see citing works

Factors impacting complication rates for catheter ablation of atrial fibrillation from 2003 to 2015

Yang, E., İpek, E. G., Balouch, M. A., Mints, Y. Y., Chrispin, J., Marine, J. E., Berger, R. D., Ashikaga, H., Rickard, J., Calkins, H. G., et al. (2016) · EP Europace · doi:10.1093/europace/euw178 · Cited by 53 · see citing works

New oral anticoagulants compared to warfarin for perioperative anticoagulation in patients undergoing atrial fibrillation catheter ablation: a meta-analysis of continuous or interrupted new oral anticoagulants during ablation compared to interrupted or continuous warfarin

Zhao, Y., Yang, Y., Tang, X., Xiang, Y., Zhang, L., & Xiao, H. (2017) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-016-0221-7 · Cited by 46 · see citing works

2025 Clinical practice guidelines for Atrial fibrillation and flutter

Golukhova, E. Z., Sp, G., Михайлов, Е. Н., Revishvili, A. S. H., Arakelyan, M. G., Vasilyeva, E. Y., Davtyan, K. V., Drapkina, O. M., Drozdova, L. Y., Станиславовна, К. Е., et al. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6668 · Cited by 44 · see citing works

Periprocedural management of anticoagulation in patients taking novel oral anticoagulants: Review of the literature and recommendations for specific populations and procedures

Mar, P. L., Familtsev, D., Ezekowitz, M. D., Lakkireddy, D., & Gopinathannair, R. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.09.035 · Cited by 40 · see citing works

Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation

Biase, L. D., Callans, D. J., Hæusler, K. G., Hindricks, G., Al‐Khalidi, H. R., Mont, L., Nielsen, J. C., Piccini, J. P., Schotten, U., & Kirchhof, P. F. (2016) · EP Europace · doi:10.1093/europace/euw368 · Cited by 40 · see citing works

Significant Benefit of Uninterrupted DOACs Versus VKA During Catheter Ablation of Atrial Fibrillation

Romero, J. E., Cerrud-Rodriguez, R. C., Alviz, I., Díaz, J. C., Rodríguez, D., Arshad, S., Cerna, L. E., Taveras, J. M., Grupposo, V., Natale, A., et al. (2019) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2019.08.010 · Cited by 39 · see citing works

When is it appropriate to stop non-vitamin K antagonist oral anticoagulants before catheter ablation of atrial fibrillation? A multicentre prospective randomized study

Yu, H. T., Shim, J., Park, J., Kim, T., Uhm, J., Kim, J., Joung, B., Lee, M., Kim, Y., & Pak, H. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy870 · Cited by 37 · see citing works

Antithrombotic Therapy for Patients Undergoing Cardiac Electrophysiological and Interventional Procedures

Biase, L. D., Lakkireddy, D. J., Marazzato, J., Velasco, A., Díaz, J. C., Navara, R., Chrispin, J., Rajagopalan, B., Natale, A., Mohanty, S., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.09.831 · Cited by 34 · see citing works

Silent Cerebral Ischemic Lesions After Catheter Ablation of Atrial Fibrillation in Patients on 5 Types of Periprocedural Oral Anticoagulation – Predictors of Diffusion-Weighted Imaging-Positive Lesions and Follow-up Magnetic Resonance Imaging –

Nakamura, K., Naito, S., Sasaki, T., Minami, K., Take, Y., Goto, E., Shimizu, S., Yamaguchi, Y., Suzuki, N., Yano, T., et al. (2016) · Circulation Journal · doi:10.1253/circj.cj-15-1368 · Cited by 34 · see citing works

Is transesophageal echocardiography necessary in patients undergoing ablation of atrial fibrillation on an uninterrupted direct oral anticoagulant regimen? Results from a prospective multicenter registry

Patel, K., Natale, A., Yang, R., Trivedi, C. G., Romero, J. E., Briceno, D. F., Mohanty, S., Alviz, I., Natale, V. N., Sánchez, J., et al. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.07.017 · Cited by 31 · see citing works

Impact of periprocedural anticoagulation strategy on the incidence of new-onset silent cerebral events after radiofrequency catheter ablation of atrial fibrillation

Müller, P., Halbfaß, P., Szöllösi, A., Dietrich, J. W., Fochler, F., Nentwich, K., Roos, M., Krug, J., Schmitt, R. R., Mügge, A., et al. (2016) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-016-0117-6 · Cited by 31 · see citing works

Trends in Transesophageal Echocardiography Use, Findings, and Clinical Outcomes in the Era of Minimally Interrupted Anticoagulation for Atrial Fibrillation Ablation

Balouch, M. A., İpek, E. G., Chrispin, J., Bajwa, R. J., Zghaib, T., Berger, R. D., Ashikaga, H., Calkins, H. G., Nazarian, S., Marine, J. E., et al. (2016) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2016.09.011 · Cited by 31 · see citing works

Qualitätskriterien zur Durchführung der Katheterablation von Vorhofflimmern

Kück, K., Böcker, D., Chun, K. R. J., Deneke, T., Hindricks, G., Hoffmann, E., Piorkowski, C., & Willems, S. (2017) · Der Kardiologe · doi:10.1007/s12181-017-0146-0 · Cited by 31 · see citing works

Efficacy and Safety of Rivaroxaban and Warfarin in the Perioperative Period of Catheter Ablation for Atrial Fibrillation – Outcome Analysis From a Prospective Multicenter Registry Study in Japan –

Okumura, K., Aonuma, K., Kumagai, K., Hirao, K., Inoue, K., Kimura, M., Miyauchi, Y., Tsushima, E., & for the JACRE Investigators (2016) · Circulation Journal · doi:10.1253/circj.cj-16-0621 · Cited by 30 · see citing works

Meta-Analysis of Effectiveness and Safety of Oral Anticoagulants in Atrial Fibrillation With Focus on Apixaban

Bai, Y., Shi, X.-B., Ma, C., & Lip, G. Y. H. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.07.072 · Cited by 28 · see citing works

Uninterrupted New Oral Anticoagulants Compared With Uninterrupted Vitamin K Antagonists in Ablation of Atrial Fibrillation: A Meta-analysis

Nairooz, R. S., Ayoub, K. F., Sardar, P., Payne, J. J., Almomani, A. A., Pothineni, N. V. K., Shailesh, F., Aronow, W. S., & Mukherjee, D. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.09.012 · Cited by 27 · see citing works

Ablation of Atrial Fibrillation Without Left Atrial Appendage Imaging in Patients Treated With Direct Oral Anticoagulants

Diab, M., Wazni, O. M., Saliba, W. I., Tarakji, K. G., Ballout, J. A., Hutt, E., Rickard, J., Baranowski, B. J., TCHOU, P. J., Bhargava, M., et al. (2020) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.119.008301 · Cited by 27 · see citing works

Efficacy and safety of rivaroxaban compared with vitamin K antagonists for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis

Vámos, M., Cappato, R., Marchlinski, F. E., Natale, A., & Hohnloser, S. H. (2016) · EP Europace · doi:10.1093/europace/euv408 · Cited by 25 · see citing works

Current status of catheter ablation of atrial fibrillation in Japan: Summary of the 4th survey of the Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF)

Inoue, K., Murakawa, Y., Nogami, A., Shoda, M., Naito, S., Kumagai, K., Miyauchi, Y., Yamane, T., Morita, N., & Okumura, K. (2015) · Journal of Cardiology · doi:10.1016/j.jjcc.2015.08.011 · Cited by 25 · see citing works

Prevalence of left atrial appendage thrombus detected by transoesophageal echocardiography before catheter ablation of atrial fibrillation in patients anticoagulated with non-vitamin K antagonist oral anticoagulants

Alqarawi, W., Birnie, D. H., Spence, S., Ramirez, F. D., Redpath, C. J., Lemery, R., Nair, G. M., Nery, P. B., Davis, D. R., Green, M. S., et al. (2018) · EP Europace · doi:10.1093/europace/euy129 · Cited by 24 · see citing works

Management of Intraprocedural Anticoagulation in Patients on Non-Vitamin K Antagonist Oral Anticoagulants Undergoing Catheter Ablation for Atrial Fibrillation

Martin, A., Godiér, A., Narayanan, K., Smadja, D. M., & Marijon, É. (2018) · Circulation · doi:10.1161/circulationaha.117.033326 · Cited by 23 · see citing works

Complications of Atrial Fibrillation Cryoablation

Canpolat, U. (2017) · Journal of Atrial Fibrillation · doi:10.4022/jafib.1620 · Cited by 22 · see citing works

Perioperative Safety and Efficacy of Different Anticoagulation Strategies With Direct Oral Anticoagulants in Pulmonary Vein Isolation

Gorla, R., Dentali, F., Crippa, M., Marazzato, J., Minno, M. N. D. D., Grandi, A. M., & Ponti, R. D. (2018) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2018.04.006 · Cited by 20 · see citing works

Comparison of prevalence and management of left atrial appendage thrombi under old and new anticoagulants prior to left atrial catheter ablation

Costa, A. D., Delolme, C., Guichard, J.-B., Gerbay, A., Pierrard, R., Romeyer-Bouchard, C., & Isaaz, K. (2017) · American Heart Journal · doi:10.1016/j.ahj.2017.07.016 · Cited by 20 · see citing works

Impact of the type of electroanatomic mapping system on the incidence of cerebral embolism after radiofrequency catheter ablation of left atrial tachycardias

Nakamura, K., Sasaki, T., Take, Y., Minami, K., Inoue, M., Kishi, S., Yoshimura, S., Sasaki, W., Okazaki, Y., Motoda, H., et al. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.09.009 · Cited by 20 · see citing works

Transesophageal vs. intracardiac echocardiographic screening in patients undergoing atrial fibrillation ablation with uninterrupted rivaroxaban

Tsyganov, A., Shapieva, A. N., Va, S., Вячеславовна, Ф. С., Mironovich, S., Николаевна, Д. А., & Lyan, E. (2017) · BMC Cardiovascular Disorders · doi:10.1186/s12872-017-0607-1 · Cited by 19 · see citing works

Uninterrupted Direct Oral Anticoagulant and Warfarin Administration in Elderly Patients Undergoing Catheter Ablation for Atrial Fibrillation

Yanagisawa, S., Inden, Y., Fujii, A., Ando, M., Funabiki, J., Murase, Y., Takenaka, M., Otake, N., Ikai, Y., Sakamoto, Y., et al. (2018) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2018.02.013 · Cited by 19 · see citing works

Continuous and minimally-interrupted direct oral anticoagulant are both safe compared with vitamin K antagonist for atrial fibrillation ablation: An updated meta-analysis

Ha, F. J., Barra, S., Brown, A. J., Begley, D., Grace, A. A., & Agarwal, S. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.03.095 · Cited by 18 · see citing works

Management of Periprocedural and Early Pericardial Effusions With Tamponade Following Ablation of Atrial Fibrillation With Uninterrupted Factor Xa Inhibitors: A Case Series

Gianni, C., Biase, L. D., Mohanty, S., Trivedi, C. G., Bai, R., Al‐Ahmad, A., Burkhardt, J. D., Gallinghouse, G. J., Horton, R., Sánchez, J., et al. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12918 · Cited by 18 · see citing works

Differences in prothrombotic response between the uninterrupted and interrupted apixaban therapies in patients undergoing cryoballoon ablation for paroxysmal atrial fibrillation: a randomized controlled study

Ando, M., Inden, Y., Yoshida, Y., Sairaku, A., Yanagisawa, S., Suzuki, H., Watanabe, R., Takenaka, M., Maeda, M., & Murohara, T. (2019) · Heart and Vessels · doi:10.1007/s00380-019-01370-9 · Cited by 18 · see citing works

Higher initial weight-based heparin dosing is required with direct oral anticoagulants during catheter ablation for atrial fibrillation

Payne, J., Koerber, S. M., Bickel, T., Ghadban, R., Flaker, G. C., & Gautam, S. (2019) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-019-00579-y · Cited by 17 · see citing works

A Patient With Asymptomatic Cerebral Lesions During AF Ablation: How Much Should We Worry?

Forleo, G. B., Rocca, D. G. D., Lavalle, C., Mantica, M., Papavasileiou, L. P., Ribatti, V., Panattoni, G., Santini, L., Natale, A., & Biase, L. D. (2016) · PubMed Central · doi:10.4022/jafib.1323 · Cited by 17 · see citing works

Meta-analysis of efficacy and safety of apixaban and uninterrupted apixaban therapy compared to vitamin K antagonists in patients undergoing catheter ablation for atrial fibrillation

Ukaigwe, A. C., Shrestha, P., Karmacharya, P., HUSSAIN, S. K., Samii, S. M., Gonzalez, M. D., Wolbrette, D. L., & Naccarelli, G. V. (2016) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-016-0195-5 · Cited by 16 · see citing works

Safety and efficacy of nonvitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: A systematic review and meta‐analysis

Ge, Z., Faggioni, M., Baber, U., Sartori, S., Sorrentino, S., Farhan, S., Chandrasekhar, J., Vogel, B., Qadeer, A., Halperin, J. L., et al. (2018) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12457 · Cited by 15 · see citing works

Bilateral Mechanical Thrombectomies for Simultaneous MCA Occlusions

Storey, C. M., Lebovitz, J. J., Sweid, A., Tjoumakaris, S. I., Gooch, R., Rosenwasser, R. H., & Jabbour, P. M. (2019) · World Neurosurgery · doi:10.1016/j.wneu.2019.08.236 · Cited by 15 · see citing works

Effect of pre-procedural interrupted apixaban on heparin anticoagulation during catheter ablation for atrial fibrillation: a prospective observational study

Abdulhak, A. A. B., Kennedy, K. F., Gupta, S. K., Giocondo, M. J., Ramza, B. M., & Wimmer, A. P. (2015) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-015-0048-7 · Cited by 14 · see citing works

Efficacy and Safety of Novel Oral Anticoagulants for Atrial Fibrillation Ablation: An Updated Meta-Analysis

Vallakati, A., Sharma, A., Madmani, M. E., Reddy, M., Kanmanthareddy, A., Gunda, S., Lakkireddy, D., & Lewis, W. R. (2016) · Cardiology and Therapy · doi:10.1007/s40119-016-0061-7 · Cited by 14 · see citing works

Renal function and risk of stroke and bleeding in patients undergoing catheter ablation for atrial fibrillation: Comparison between uninterrupted direct oral anticoagulants and warfarin administration

Yanagisawa, S., Inden, Y., Fujii, A., Ando, M., Funabiki, J., Murase, Y., Takenaka, M., Otake, N., Ikai, Y., Sakamoto, Y., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.10.033 · Cited by 13 · see citing works

Evidence of relevant electrical connection between the left atrial appendage and the great cardiac vein during catheter ablation of atrial fibrillation

Biase, L. D., Romero, J. E., Briceno, D. F., Valderrábano, M., Sánchez, J., Rocca, D. G. D., Mohanty, P. K., Horton, R., Gallinghouse, G. J., Mohanty, S., et al. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.02.009 · Cited by 13 · see citing works

Meta-Analysis of Safety and Efficacy of Uninterrupted Non–Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists for Catheter Ablation of Atrial Fibrillation

Elgendy, A. Y., Mahtta, D., Barakat, A. F., Abuzaid, A., Mahmoud, A., Mentias, A. G., Mahmoud, A. N., & Elgendy, I. Y. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.07.096 · Cited by 12 · see citing works

Rebound thrombosis within 24 hours after interruption of therapy with rivaroxaban

Bakhit, A., Selim, A. M. A., Fatima, U., & Dahhan, A. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.03.148 · Cited by 12 · see citing works

Apixaban for periprocedural anticoagulation during catheter ablation of atrial fibrillation: a systematic review and meta-analysis of 1691 patients

Blandino, A., Bianchi, F., Biondi‐Zoccai, G., Grossi, S., Conte, M. R., Rametta, F., & Gaïta, F. (2016) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-016-0141-6 · Cited by 12 · see citing works

Safety and Efficacy of Uninterrupted Apixaban Therapy Versus Warfarin During Atrial Fibrillation Ablation

Shah, R. R., Pillai, A., Schafer, P. E., Meggo, D., McElderry, T., Plumb, V. J., Yamada, T., Kumar, V., Doppalapudi, H., Gunter, A., et al. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.04.041 · Cited by 12 · see citing works

Reversal Agents in the Era of NOACs: 2017 Update

Sy, R. W. (2017) · Journal of Atrial Fibrillation · doi:10.4022/jafib.1634 · Cited by 12 · see citing works

WITHDRAWN: 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation

Calkins, H. G., Hindricks, G., Cappato, R., Kim, Y., Saad, E., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, A. J., et al. (2017) · Journal of Arrhythmia · doi:10.1016/j.joa.2017.07.001 · Cited by 11 · see citing works

Interrupted or Uninterrupted Oral Anticoagulants in Patients Undergoing Atrial Fibrillation Ablation

Yang, P., Wang, C., Ye, Y., Huang, T., Yang, S., Shen, W., Xu, G., & Wu, Q. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-06967-1 · Cited by 11 · see citing works

Safety And Efficacy Of Uninterrupted Periprocedural Apixaban In Patients Undergoing Atrial Fibrillation Catheter Ablation: A Metaanalysis Of 1,057 Patients.

Garg, J., Chaudhary, R., Krishnamoorthy, P. M., Shah, N. N., Bozorgnia, B., & Natale, A. (2016) · PubMed Central · doi:10.4022/jafib.1368 · Cited by 11 · see citing works

Incidence and predictors of silent cerebral thromboembolic lesions after catheter ablation for atrial fibrillation in patients treated with direct oral anticoagulants

Doi, A., Takagi, M., Kakihara, J., Hayashi, Y., Tatsumi, H., Fujimoto, K., Sugioka, K., & Yoshiyama, M. (2017) · Heart and Vessels · doi:10.1007/s00380-017-0985-4 · Cited by 11 · see citing works

Thromboembolic and bleeding risks in patients undergoing atrial fibrillation ablation: oral anticoagulation perspectives

Briceno, D. F., Madan, N., Romero, J. E., Jimenez, A. L., Villablanca, P. A., Natale, A., & Biase, L. D. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1325867 · Cited by 11 · see citing works

Update on Direct Oral Anticoagulants in Atrial Fibrillation Patients Undergoing Cardiac Interventional Procedures: From Clinical Trials to Real-World Evidence

Melillo, E., Carbone, A., Rago, A., Papa, A. A., Onofrio, A. D., Nigro, G., Golino, P., & Russo, V. (2019) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000786 · Cited by 11 · see citing works

Peri‐procedural novel oral anticoagulants dosing strategy during atrial fibrillation ablation: A meta‐analysis

Mao, Y., Wang, H., & Huang, P. (2020) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14040 · Cited by 11 · see citing works

Incidence and characteristics of silent cerebral embolisms after radiofrequency‐based atrial fibrillation ablation: A propensity score‐matched analysis between different mapping catheters and indices for guiding ablation

Nakamura, K., Sasaki, T., Take, Y., Minami, K., Inoue, M., Asahina, C., Sasaki, W., Kishi, S., Yoshimura, S., Okazaki, Y., et al. (2020) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14800 · Cited by 11 · see citing works

Perioperative anticoagulant management in patients with atrial fibrillation: practical implications of recent clinical trials

Tafur, A. J., & Douketis, J. D. (2015) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.3049 · Cited by 10 · see citing works

Heparin Kinetics: The “Holy Grail” of Periprocedural Anticoagulation for Ablation of Atrial Fibrillation

Briceno, D. F., Natale, A., & Biase, L. D. (2015) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12683 · Cited by 10 · see citing works

Radiofrequency Catheter Ablation: How to Manage and Prevent Collateral Damage?

El‐Baba, M., Sabayon, M. D., & Refaat, M. M. (2020) · Journal of Innovations in Cardiac Rhythm Management · doi:10.19102/icrm.2020.110901 · Cited by 10 · see citing works

Meta‐Analysis of Efficacy and Safety of Apixaban in Patients Undergoing Catheter Ablation for Atrial Fibrillation

Lu, D., Liu, Q., Wang, K., Zhang, Q., & Shan, Q. (2015) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12771 · Cited by 10 · see citing works

Influence of periprocedural anticoagulation strategies on complication rate and hospital stay in patients undergoing catheter ablation for persistent atrial fibrillation

Gunawardene, M., Willems, S., Schäffer, B., Moser, J. S., Akbulak, R. Ö., Jularic, M., Eickholt, C., Nührich, J. M., Meyer, C. G., Kuklik, P., et al. (2016) · Clinical Research in Cardiology · doi:10.1007/s00392-016-1021-x · Cited by 10 · see citing works

Periprocedural Anticoagulation Management for Atrial Fibrillation Ablation: Current Knowledge and Future Directions

Sugrue, A. M., Siontis, K. C., Piccini, J. P., & Noseworthy, P. A. (2018) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-018-0600-8 · Cited by 10 · see citing works

Intracardiac Fibrinolysis and Endothelium Activation Related to Atrial Fibrillation Ablation with Different Techniques

Hajas, O., Bagoly, Z., Tóth, N. K., Urbancsek, R., Kiss, A., Kovács, K. B., Sarkady, F., Nagy, A. C., Oláh, A. V., Nagy, L., et al. (2020) · Cardiology Research and Practice · doi:10.1155/2020/1570483 · Cited by 10 · see citing works

Non-valvular atrial fibrillation: impact of apixaban on patient outcomes

Ioannou, A., Tsappa, I., Metaxa, S., & Missouris, C. G. (2017) · Patient Related Outcome Measures · doi:10.2147/prom.s117549 · Cited by 10 · see citing works

Cerebral thromboembolic risk in atrial fibrillation ablation: a direct comparison of vitamin K antagonists versus non-vitamin K-dependent oral anticoagulants

Petzl, A. M., Derndorfer, M., Κόλλιας, Γ., Moroka, K., Aichinger, J., Pürerfellner, H., & Martinek, M. (2020) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-020-00718-w · Cited by 9 · see citing works

Periprocedural Management of Novel Oral Anticoagulants During Atrial Fibrillation Ablation: Controversies and Review of the Current Evidence

Abed, H. S., Chen, V. M. Y., Kilborn, M. J., & Sy, R. W. (2016) · Heart Lung and Circulation · doi:10.1016/j.hlc.2016.04.027 · Cited by 8 · see citing works

Periprocedural and long-term safety and feasibility of direct oral anticoagulants in patients with biological valve undergoing radiofrequency catheter ablation for atrial fibrillation: a prospective multicenter study

Biase, L. D., Romero, J. E., Briceno, D. F., Lakkireddy, D., Trivedi, C. G., Mohanty, P. K., Mohanty, S., Horton, R., Hranitzky, P. M., Gallinghouse, G. J., et al. (2020) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-020-00833-8 · Cited by 8 · see citing works

2018 KHRS Expert Consensus Recommendation for Oral Anticoagulants Choice and Appropriate Doses: Specific Situation and High Risk Patients

Lee, K. H., Joung, B., Lee, S., Hwang, Y. M., Park, J., Baek, Y., Park, Y. M., Park, J., Park, H. C., Park, H. W., et al. (2018) · Korean Journal of Medicine · doi:10.3904/kjm.2018.93.2.110 · Cited by 7 · see citing works

Minimally interrupted novel oral anticoagulant versus uninterrupted vitamin K antagonist during atrial fibrillation ablation

de Heide, J., Vroegh, C. J., Bhagwandien, R. E., Wijchers, S. A., Szili‐Törok, T., Zijlstra, F., Lenzen, M. J., & Yap, S. (2018) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-018-0417-0 · Cited by 7 · see citing works

The 2018 Korean Heart Rhythm Society Practical Guidelines on the use of Non-Vitamin K-Antagonist Oral Anticoagulants: Bleeding Control and Perioperative Management

Lee, J. H., Lim, H. E., Lim, W., Ahn, J., Cha, M., Park, J., Lee, K. H., Park, H.-C., Choi, E., & Joung, B. (2019) · Korean Journal of Medicine · doi:10.3904/kjm.2019.94.1.40 · Cited by 7 · see citing works

Peri-procedural use of direct anticoagulation agents during cardiac device implantation: vitamin K antagonists vs direct oral anticoagulants

Pillarisetti, J., Maybrook, R. J., Parikh, V. K., Adabala, N. P., Khalafi, M., Reddy, S., Bommana, S., Lakkireddy, P., Reddy, M. Y., Gianni, C., et al. (2019) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-019-00646-4 · Cited by 7 · see citing works

Feasibility and safety of uninterrupted apixaban in patients undergoing radiofrequency ablation for atrial fibrillation

Osaka, Y., Ono, Y., Tao, S., Goto, K., Miyazaki, T., Suzuki, A., Kurihara, K., Otomo, K., & Hirao, K. (2019) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-019-00563-6 · Cited by 7 · see citing works

Uninterrupted Apixaban Safe and Effective in AF Ablation

Nichols, E. H., & Biase, L. D. (2015) · MD Conference Express · doi:10.1177/1559897715598150

Uninterrupted apixaban for atrial fibrillation ablation is a reasonable alternative, but what is the significance of silent cerebral infarctions?

Friedman, D. J., & Granger, C. B. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy274 · Cited by 2 · see citing works

Safety and Efficacy of Uninterrupted Apixaban Therapy Versus Warfarin During Atrial Fibrillation Ablation

Shah, R. R., Pillai, A., Schafer, P. E., Meggo, D., McElderry, T., Plumb, V. J., Yamada, T., Kumar, V., Doppalapudi, H., Gunter, A., et al. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.04.041 · Cited by 12 · see citing works

Apixaban versus Warfarin for the Prevention of Periprocedural Cerebral Thromboembolism in Atrial Fibrillation Ablation: Multicenter Prospective Randomized Study

Kuwahara, T., Abe, M., Yamaki, M., Fujieda, H., Abe, Y., HASHIMOTO, K., ISHIBA, M., Sakai, H., Hishikari, K., Takigawa, M., et al. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12928 · Cited by 87 · see citing works